Epidemiologic studies indicate that caffeine consumption, a non-selective antagonist of adenosine A2A receptors, is associated with a low risk of development of AD, PD, and dementia, decreasing the cognitive decline of aging [38,78]. This evidence concerns the gene ADORA2A and dementia.